upadacitinib,linaclotide,risankizumab
Abbvie,ironwood pharmaceutical,Boehringer Ingelheim
['$abbv', 'abbvie']
$abbv abbvie releases new data demonstrating breadth of its gastroenterology portfolio at 2023 digestive disease week 
¬ Retweeting Bloomberg's Feed all in one place.

¬ Market & Stock Updates

¬ I'm Barry Bloomberg putting out the fastest updates!

¬ Making your life easier.